Virginia Retirement Systems’s Viking Therapeutics VKTX Stock Holding History

Virginia Retirement Systems’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,700	Closed	-$76K	–	1090
2021 Q2	$76K	Sell	12,700 -27,700	-69%	-$164K	﹤0.01%	1007
2021 Q1	$256K	Sell	40,400 -43,300	-52%	-$305K	﹤0.01%	1030
2020 Q4	$471K	Sell	83,700 -2,000	-2%	-$12.1K	﹤0.01%	862
2020 Q3	$499K	Sell	85,700 -3,000	-3%	-$20.7K	0.01%	770
2020 Q2	$640K	Sell	88,700 -17,000	-16%	-$113K	0.01%	717
2020 Q1	$495K	Buy	105,700 +5,500	+5%	+$33.8K	0.01%	799
2019 Q4	$804K	Sell	100,200 -2,600	-3%	-$19K	0.01%	772
2019 Q3	$707K	Sell	102,800 -1,300	-1%	-$9.65K	0.01%	796
2019 Q2	$864K	Buy	104,100 +86,300	+485%	+$737K	0.01%	723
2019 Q1	$177K	Buy	+17,800	New	+$149K	﹤0.01%	1042

Other funds holding VKTX

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Virginia Retirement Systems's VKTX Position: Q3 2021 in Review

Virginia Retirement Systems sold out of Viking Therapeutics (VKTX) in Q3 2021, closing a stake of 12,700 shares — an estimated $76K sold.

Virginia Retirement Systems first reported a position in VKTX in Q1 2019 and held it in 10 quarters. The position peaked at $864K in Q2 2019. 134 funds tracked by Wall St. Rank hold VKTX as of Q3 2021.

Virginia Retirement Systems reported no remaining Viking Therapeutics position as of Q3 2021 after selling out during the quarter.
Virginia Retirement Systems sold 12,700 Viking Therapeutics shares in Q3 2021, an estimated $76K.
Virginia Retirement Systems first reported a position in Viking Therapeutics in Q1 2019 and held it in 10 quarters.
Virginia Retirement Systems's Viking Therapeutics position peaked at $864K in Q2 2019.
134 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2021.

Based on Virginia Retirement Systems's 13F filing for Q3 2021, filed 21 Oct 2021.